Kratom Use in the United States: What Clinicians Should Know
We spoke with 2 experts about the use of kratom in the US for pain, mood, and anxiety-related issues, and what are the key implications for clinicians.
We spoke with 2 experts about the use of kratom in the US for pain, mood, and anxiety-related issues, and what are the key implications for clinicians.
This study looked at whether insomnia or pain can predict depression, anxiety or suicide in young people.
Investigators searched publication databases from inception through to July 2021 for studies about loneliness in the perinatal setting for this meta-synthesis.
Investigators sought to evaluate the association of comorbid PD and SUD with the probability of hospitalization among patients with COVID-19 in the emergency department.
Investigators designed this study to evaluate the feasibility and potential utility of a peer-led CBT-based workshop for PPD.
Investigators sought to assess the association between long-term joint exposure to multiple air pollutants and incident depression and anxiety.
Researchers assessed the differences in quality of life overall, and by age and sex, across individual disorders of gut-brain interaction.
Exxua (previously named Travivo) is a novel oral serotonin 1A receptor agonist.
Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.
In a prospective, longitudinal study, researchers assessed the effect of demographics, pre-COVID-19 comorbidities, index COVID-19 hospitalization metrics, and life stressors on 6- and 12-month outcome metrics in adult patients post-COVID-19 hospitalization.